{
  "trial_id": "NCT04604223",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age 21-85 years",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients of both sexes will be included",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "COVID-19 infection confirmed with PCR test",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Manifest at least one COVID-19 symptoms (Fever, Chills, Headache, Rhinorreah, Cough (dry or with sputum), Sore Throat, shortness of breath, Hemoptysis, Altered mentation, Fatigue/Malaise)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Diabetes and COVID-19 diagnoses",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patient clinical condition through hospitalization precludes the use of pioglitazone (primarily due to fluid retention)",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Patient is transferred to other medical facility due to space issues (eg. transfer to field hospital)",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has type 1 diabetes and COVID-19 infection, confirmed with PCR test. He presents with hyperglycemia and concern for possible diabetic ketoacidosis after not taking his insulin for 3 days.",
  "_meta": {
    "topic_id": "29",
    "trial_id": "NCT04604223",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}